relapse phenotype
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| beta activity | biomarker_for | relapse | — | 2 |
| CNS disinhibition | biomarker_for | relapse | — | 1 |
| neuroticism | risk_factor_for | relapse | — | 1 |
Mentioned in (42)
Papers in which this entity is mentioned.
- A guide to transcriptomic deconvolution in cancer. (2026)
- Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. (2025)
- Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
- A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. (2024)
- Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. (2023)
- Predicting Alcohol-Related Memory Problems in Older Adults: A Machine Learning Study with Multi-Domain Features. (2023)
- The Collaborative Study on the Genetics of Alcoholism: Overview. (2023)
- Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
- Cell-free DNA technologies for the analysis of brain cancer. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. (2022)
- Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. (2022)
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
- Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
- Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
- Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
- How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia. (2019)
- Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
- Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. (2019)
- CALDER: Inferring Phylogenetic Trees from Longitudinal Tumor Samples. (2019)
- Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. (2018)
- Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. (2018)
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- Copy-number signatures and mutational processes in ovarian carcinoma (2017)
- Statistical modeling for sensitive detection of low-frequency single nucleotide variants. (2016)
- A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
- Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. (2016)
- Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. (2015)
- Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. (2015)
- Clonal evolution in hematological malignancies and therapeutic implications. (2014)
- Effects of alcohol on the endocrine system. (2013)
- Molecular genetics of B-precursor acute lymphoblastic leukemia. (2012)
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
- Patient-derived tumour xenografts as models for oncology drug development. (2012)
- The Pediatric Cancer Genome Project. (2012)
- Transcriptional and epigenetic mechanisms of addiction. (2011)
- Alcoholism and human electrophysiology. (2003)
Merged raw entities (11)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| relapse | phenotype | 111 | 266 |
| relapse to heavy drinking | phenotype | 1 | 2 |
| alcoholics who relapse | phenotype | — | — |
| days until relapse | phenotype | — | — |
| relapse due to withdrawal symptoms | phenotype | — | — |
| relapse in alcohol | phenotype | — | — |
| relapse outcomes | phenotype | — | — |
| relapse to drug seeking | phenotype | — | — |
| relapse to drug taking | phenotype | — | — |
| relapse to use | phenotype | — | — |
| use or relapse | phenotype | — | — |